je.st
news
Home
› Mesothelioma Immunotherapy Vaccine Receives Orphan Drug Designation From FDA, Baron & Budd Reports
Mesothelioma Immunotherapy Vaccine Receives Orphan Drug Designation From FDA, Baron & Budd Reports
2015-04-29 04:58:10| drugdiscoveryonline Home Page
The mesothelioma law firm of Baron & Budd reports the U.S
Tags: reports
drug
receives
designation
Category:Biotechnology and Pharmaceuticals